In Meraouna et al.'s study, the failure-free survival rate was 66% at 3 years of follow-up. Regarding treatment-related morbidities, 12.3% of patients experienced grade 3 genitourinary (GU) toxicity, ...

The letter also stated that "gross medical incompetence" is prevalent ... when the patient was diagnosed with metastatic prostate cancer. The report didn't identify the person involved but said ...